Brief: Nanostring Launches Ncounter Antibody Drug Conjugate Panel To Accelerate The Development Of Oncology Treatments
Oct 12 (Reuters) - NanoString Technologies Inc NSTG.O :
* NANOSTRING LAUNCHES NCOUNTER ANTIBODY DRUG CONJUGATE PANEL
TO
ACCELERATE THE DEVELOPMENT OF ONCOLOGY TREATMENTS
Source text for Eikon: ID:nBwbF4TS3a
Further company coverage: NSTG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NS Wind Down Co
See all newsBruker slides after 6 mln share offering priced
Brief: Nanostring Technologies To Be Acquired By Bruker Corporation
Brief: Patient Square Capital Agrees To Acquire Nanostring Technologies
U.S. STOCKS ON THE MOVE-New York Community Bancorp, Ralph Lauren, Newell Brands
U.S. STOCKS ON THE MOVE-Take-Two Interactive, PepsiCo, Moderna